Background -Endothelin is a potent bronchoconstrictor which appears to be important in asthma. To ascertain whether cigarette smoking is associated with any alteration in the proportion ofbronchiolar epithelial cells which express endothelin immunoreactivity, the airways in the lungs of non-smokers and smokers were analysed. Since Airways responsiveness also appears to be important in the alteration of pulmonary function seen in cigarette smokers. As a result of the known similarity in the airways disease of asthmatic subjects and cigarette smokers6`we speculated that cigarette smoking may produce an increased expression of endothelin in the bronchiolar epithelial cells. A morphometric analysis was therefore performed to examine the proportion ofimmunoreactive epithelial cells in the respiratory and membranous bronchioles in (1) groups of non-smokers and smokers with no knowledge oftheir bronchial responsiveness, and (2) groups of non-smokers and smokers in whom bronchial responsiveness had been measured before pulmonary resection by methacholine challenge.
Endothelins are a group of peptides which produce considerable bronchoconstriction.l Bronchial epithelial cells have been found to produce the peptide in culture,2 and morphological studies have shown immunoreactive peptide in the bronchial and bronchiolar cells of human airways.3 Furthermore, bronchial smooth muscle cells have specific binding sites for endothelin,4 and endothelin is known to act as a potent mitogen for smooth muscle cells.'
Airways responsiveness also appears to be important in the alteration of pulmonary function seen in cigarette smokers. As a result of the known similarity in the airways disease of asthmatic subjects and cigarette smokers6`we speculated that cigarette smoking may produce an increased expression of endothelin in the bronchiolar epithelial cells. A morphometric analysis was therefore performed to examine the proportion ofimmunoreactive epithelial cells in the respiratory and membranous bronchioles in (1) groups of non-smokers and smokers with no knowledge oftheir bronchial responsiveness, and (2) groups of non-smokers and smokers in whom bronchial responsiveness had been measured before pulmonary resection by methacholine challenge.
Methods
The patients were part of a larger structure function study in our institution. All had undergone lobectomy or pneumonectomy for a mass lesion, usually carcinoma. For the initial study five lifetime non-smokers were selected and matched for age with an equal number of current smokers who had a wide range of smoking histories. Smoking history was expressed as pack years.
For the second study subjects were selected from a subgroup ofpatients who had performed a methacholine challenge before surgery. Matched with the general smokers for total smoking history, a group of five smokers were selected who had responded to low concentrations of methacholine (range 0-23-1 48, geometric mean 0 53, arithmetic mean 0 74 mg/ml) with a drop of 20% in their FEV,, and a second group of five patients who did not exhibit such a response (methacholine PCG, range 14 9->16 mg/ml).
All lungs were treated in a similar manner. They were fixed in inflation with buffered formalin and random sections were taken from the medial and lateral slices and processed in paraffin. Sections 4 pim thick were mounted on slides and immunostained for endothelin reactivity by the avidin-biotin-peroxidase (ABP) technique. In brief, sections were first deparaffinised and endogenous peroxidase was blocked by incubation with hydrogen peroxide. After washing with phosphate buffered saline (PBS) the sections were incubated overnight at room temperature with anti-endothelin antibody (Serotec) in a dilution of 1:4000. Following a PBS wash the sections were incubated for one hour at room temperature with biotinylated antimouse IgG (Vectastain), washed with PBS, the ABP complex (Vectastain Kit, Vector, USA) applied, and peroxidase activity revealed using 3-amino-9-ethylcarbazole chromogen. Sections were then counterstained with haematoxylin, dehydrated, cleared, and coverslipped. Negative controls were constructed by omission of the primary antibody.
The sections were examined under low power and the position of each respiratory and membranous bronchiole was identified. Using a random number generator five respiratory and membranous bronchioles were selected for analysis. With a 100 x oil immersion lens and a 42
Relation of smoking to immunoreactive endothelin in the bronchiolar epithelial cells Mean (SD) and range ofpatient data and proportion of imniunoreactive bronchiolar epithelial cells in respiratory bronchioles (RB) and membranous bronchioles (MB) Although we were only able to include groups of five patients, and it is possible that we could miss a subtle change, our data do not support this. The proportion of immunoreactive epithelial cells was similar in non-smokers and current smokers with a wide range of smoking histories, suggesting that cigarette smoking did not induce the proliferation of or stimulate the epithelial cells to produce immunoreactive endothelin. Furthermore, cigarette smokers who were known to have hyperresponsive airways had similar proportions of immunoreactive bronchial epithelial cells to those smokers who were known to have non-reactive airways. It is also important to note however that, although one of the patient groups was selected for increased response to methacholine, these patients may not have had clinical asthma. Studies by Moreno et all '8 have shown that such a response can be produced when the airways are narrowed secondarily to inflammation and scarring. Our data must not be interpreted as suggesting that endothelin is not important in patients with asthma. Unfortunately we did not have material from a clinically asthmatic non-smoking patient group.
It is also possible that it is not the steady state endothelin expression that is the important feature of bronchial hyperresponsiveness, but the degree to which endothelin production can be stimulated. The presence of endothelin in increased quantities in the bronchoalveolar lavage fluid of a patient during, compared with after, an asthmatic attack would be in keeping with this explanation. In the present study we used an immunostaining technique and therefore have expressed our data quantitatively as the proportion of immunoreactive epithelial cells. It is, however, possible that it is not the number of cells which is important but their ability to secrete increased amounts of endothelin -something which we could not assess. A further possibility relates to the mitogenic properties of endothelin; it is possible that the airway smooth muscle has been altered by numerous episodic bouts of endothelin production, and that it is this secondarily induced airway change which is responsible for the hyperresponsiveness.
We Zamboni's fixation. We used commercial polyclonal antibodies while Giaid used specific laboratory raised antibodies against endothelin I and big endothelin I; it is possible that the antibodies used by Giaid were much more specific than were those used in our study. Finally, it is possible that the lungs in our study were affected by the presence of lung neoplasms. A further study by Giaid and colleaguest°did find that airway epithelium adjacent to tumours stained positive, although they did not quantitate this change; our sections were, however, specifically taken away from the tumorous area.
In summary, this study shows that there is a wide range in the proportions of endothelin immunoreactive bronchiolar epithelial cells. 
